|
G |
ALB |
albumin |
affects binding |
EXP |
Halothane binds to ALB protein |
CTD |
PMID:17242087 |
|
NCBI chr 4:73,404,287...73,421,482
Ensembl chr 4:73,397,114...73,421,482
|
|
G |
BAX |
BCL2 associated X, apoptosis regulator |
increases expression multiple interactions |
ISO |
Halothane results in increased expression of BAX mRNA [Ryanodine co-treated with Halothane] results in increased expression of BAX mRNA; Dantrolene inhibits the reaction [Halothane results in increased expression of BAX mRNA] |
CTD |
PMID:32795494 |
|
NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
|
|
G |
BCL2L11 |
BCL2 like 11 |
multiple interactions increases expression |
ISO |
[Ryanodine co-treated with Halothane] results in increased expression of BCL2L11 mRNA; Dantrolene inhibits the reaction [Halothane results in increased expression of BCL2L11 mRNA] |
CTD |
PMID:32795494 |
|
NCBI chr 2:111,120,914...111,168,445
Ensembl chr 2:111,119,378...111,168,444
|
|
G |
CALR |
calreticulin |
affects metabolic processing |
ISO |
Halothane metabolite affects the metabolism of CALR |
CTD |
PMID:1504264 |
|
NCBI chr19:12,938,609...12,944,489
Ensembl chr19:12,938,578...12,944,489
|
|
G |
CCL2 |
C-C motif chemokine ligand 2 |
decreases expression |
ISO |
Halothane results in decreased expression of CCL2 mRNA |
CTD |
PMID:15564938 |
|
NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208
|
|
G |
CD69 |
CD69 molecule |
increases expression |
ISO |
Halothane results in increased expression of CD69 protein |
CTD |
PMID:21245496 |
|
NCBI chr12:9,752,486...9,760,901
Ensembl chr12:9,752,486...9,760,901
|
|
G |
CXCL1 |
C-X-C motif chemokine ligand 1 |
decreases expression multiple interactions increases expression |
ISO |
Halothane results in decreased expression of CXCL1 mRNA Estradiol inhibits the reaction [Halothane results in increased expression of CXCL1 mRNA]; fulvestrant inhibits the reaction [Estradiol inhibits the reaction [Halothane results in increased expression of CXCL1 mRNA]]; gadolinium chloride inhibits the reaction [Progesterone promotes the reaction [Halothane results in increased expression of CXCL1 mRNA]]; Mifepristone inhibits the reaction [Halothane results in increased expression of CXCL1 mRNA]; Mifepristone inhibits the reaction [Progesterone promotes the reaction [Halothane results in increased expression of CXCL1 mRNA]]; Progesterone promotes the reaction [Halothane results in increased expression of CXCL1 mRNA]; U 0126 inhibits the reaction [Progesterone promotes the reaction [Halothane results in increased expression of CXCL1 mRNA]] Halothane results in increased expression of CXCL1 mRNA; Halothane results in increased expression of CXCL1 protein |
CTD |
PMID:15564938 PMID:21501669 PMID:22157104 PMID:24598351 |
|
NCBI chr 4:73,869,393...73,871,308
Ensembl chr 4:73,869,393...73,871,308
|
|
G |
CXCL10 |
C-X-C motif chemokine ligand 10 |
decreases expression |
ISO |
Halothane results in decreased expression of CXCL10 mRNA |
CTD |
PMID:15564938 |
|
NCBI chr 4:76,021,118...76,023,497
Ensembl chr 4:76,021,118...76,023,497
|
|
G |
CXCL2 |
C-X-C motif chemokine ligand 2 |
increases expression multiple interactions decreases expression |
ISO |
Halothane results in increased expression of CXCL2 mRNA Halothane results in increased expression of CXCL2 mRNA; Halothane results in increased expression of CXCL2 protein [Progesterone co-treated with Halothane] results in increased expression of CXCL2 mRNA; [Progesterone co-treated with Halothane] results in increased expression of CXCL2 protein; Dantrolene inhibits the reaction [Halothane results in increased expression of CXCL2 mRNA]; Estradiol inhibits the reaction [Halothane results in increased expression of CXCL2 mRNA]; Fulvestrant inhibits the reaction [Estradiol inhibits the reaction [Halothane results in increased expression of CXCL2 mRNA]]; gadolinium chloride inhibits the reaction [[Progesterone co-treated with Halothane] results in increased expression of CXCL2 mRNA]; Mifepristone inhibits the reaction [Halothane results in increased expression of CXCL2 mRNA]; Mifepristone inhibits the reaction [Progesterone promotes the reaction [Halothane results in increased expression of CXCL2 mRNA]]; Progesterone promotes the reaction [Halothane results in increased expression of CXCL2 mRNA]; Ryanodine promotes the reaction [Halothane results in increased expression of CXCL2 mRNA]; U 0126 inhibits the reaction [[Progesterone co-treated with Halothane] results in increased expression of CXCL2 mRNA] Halothane results in decreased expression of CXCL2 mRNA |
CTD |
PMID:10422944 PMID:15564938 PMID:19633216 PMID:21501669 PMID:22157104 PMID:24598351 PMID:24747151 PMID:32795494 More...
|
|
NCBI chr 4:74,097,040...74,099,195
Ensembl chr 4:74,097,040...74,099,196
|
|
G |
CYB5A |
cytochrome b5 type A |
multiple interactions increases metabolic processing |
EXP |
diisopropyl 1,3-dithiol-2-ylidenemalonate results in increased expression of [CYB5A protein results in increased metabolism of Halothane] |
CTD |
PMID:3689822 |
|
NCBI chr18:74,250,846...74,291,963
Ensembl chr18:74,250,846...74,291,973
|
|
G |
CYP2A6 |
cytochrome P450 family 2 subfamily A member 6 |
increases metabolic processing affects metabolic processing |
EXP |
CYP2A6 protein results in increased metabolism of Halothane CYP2A6 protein affects the metabolism of Halothane |
CTD |
PMID:8886607 PMID:9103523 PMID:12487152 |
|
NCBI chr19:40,843,541...40,850,447
Ensembl chr19:40,843,541...40,850,447
|
|
G |
CYP2B6 |
cytochrome P450 family 2 subfamily B member 6 |
increases metabolic processing |
EXP |
CYP2B6 protein results in increased metabolism of Halothane |
CTD |
PMID:11684365 |
|
NCBI chr19:40,991,282...41,018,398
Ensembl chr19:40,991,282...41,018,398
|
|
G |
CYP2E1 |
cytochrome P450 family 2 subfamily E member 1 |
increases metabolic processing increases response to substance multiple interactions increases oxidation affects metabolic processing |
EXP ISO |
CYP2E1 protein results in increased metabolism of Halothane CYP2E1 protein results in increased susceptibility to Halothane Disulfiram inhibits the reaction [CYP2E1 protein results in increased oxidation of Halothane] CYP2E1 protein affects the metabolism of Halothane |
CTD |
PMID:9103523 PMID:10805064 PMID:11684365 PMID:12464242 PMID:12803597 |
|
NCBI chr10:133,527,363...133,539,123
Ensembl chr10:133,520,406...133,561,220
|
|
G |
CYP3A4 |
cytochrome P450 family 3 subfamily A member 4 |
increases metabolic processing |
EXP |
CYP3A4 protein results in increased metabolism of Halothane |
CTD |
PMID:8886607 |
|
NCBI chr 7:99,756,967...99,784,184
Ensembl chr 7:99,756,960...99,784,248
|
|
G |
DDIT3 |
DNA damage inducible transcript 3 |
multiple interactions increases expression |
ISO |
Dantrolene inhibits the reaction [Halothane results in increased expression of DDIT3 mRNA]; Ryanodine promotes the reaction [Halothane results in increased expression of DDIT3 mRNA] |
CTD |
PMID:32795494 |
|
NCBI chr12:57,516,588...57,520,517
Ensembl chr12:57,516,588...57,521,737
|
|
G |
FKBP1A |
FKBP prolyl isomerase 1A |
multiple interactions increases expression |
ISO |
Dantrolene inhibits the reaction [Halothane results in increased expression of FKBP1A mRNA]; Ryanodine promotes the reaction [Halothane results in increased expression of FKBP1A mRNA] |
CTD |
PMID:32795494 |
|
NCBI chr20:1,368,978...1,393,054
Ensembl chr20:1,368,977...1,393,164
|
|
G |
FKBP1B |
FKBP prolyl isomerase 1B |
increases expression multiple interactions |
ISO |
Halothane results in increased expression of FKBP1B mRNA [Ryanodine co-treated with Halothane] results in increased expression of FKBP1B mRNA; Dantrolene inhibits the reaction [Halothane results in increased expression of FKBP1B mRNA] |
CTD |
PMID:32795494 |
|
NCBI chr 2:24,033,206...24,063,681
Ensembl chr 2:24,049,701...24,063,681
|
|
G |
FOS |
Fos proto-oncogene, AP-1 transcription factor subunit |
increases expression |
ISO |
Halothane results in increased expression of FOS protein |
CTD |
PMID:7970238 |
|
NCBI chr14:75,278,828...75,282,230
Ensembl chr14:75,278,826...75,283,190
|
|
G |
GPT |
glutamic--pyruvic transaminase |
increases expression multiple interactions |
ISO |
Halothane results in increased expression of GPT protein Dantrolene inhibits the reaction [Halothane results in increased expression of GPT protein]; eritoran inhibits the reaction [Halothane results in increased expression of GPT protein]; Ryanodine promotes the reaction [Halothane results in increased expression of GPT protein] |
CTD |
PMID:24598351 PMID:24747151 PMID:32795494 |
|
NCBI chr 8:144,503,068...144,507,172
Ensembl chr 8:144,502,973...144,507,174
|
|
G |
HMGB1 |
high mobility group box 1 |
increases expression |
ISO |
Halothane results in increased expression of HMGB1 protein |
CTD |
PMID:21245496 PMID:24747151 |
|
NCBI chr13:30,456,704...30,617,597
Ensembl chr13:30,456,704...30,617,597
|
|
G |
HMOX1 |
heme oxygenase 1 |
multiple interactions increases expression |
ISO |
[Ryanodine co-treated with Halothane] results in increased expression of HMOX1 mRNA; Dantrolene inhibits the reaction [Halothane results in increased expression of HMOX1 mRNA] |
CTD |
PMID:32795494 |
|
NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
|
|
G |
HOMER1 |
homer scaffold protein 1 |
multiple interactions increases expression |
ISO |
Dantrolene inhibits the reaction [Halothane results in increased expression of HOMER1 mRNA]; Ryanodine promotes the reaction [Halothane results in increased expression of HOMER1 mRNA] |
CTD |
PMID:32795494 |
|
NCBI chr 5:79,372,636...79,514,134
Ensembl chr 5:79,372,636...79,514,134
|
|
G |
ICAM1 |
intercellular adhesion molecule 1 |
decreases expression increases expression multiple interactions |
ISO |
Halothane results in decreased expression of ICAM1 mRNA; Halothane results in decreased expression of ICAM1 protein Halothane results in increased expression of ICAM1 mRNA [Progesterone co-treated with Halothane] results in increased expression of ICAM1 mRNA; [U 0126 co-treated with Halothane] results in increased expression of ICAM1 mRNA; Estradiol inhibits the reaction [Halothane results in increased expression of ICAM1 mRNA]; fulvestrant inhibits the reaction [Estradiol inhibits the reaction [Halothane results in increased expression of ICAM1 mRNA]]; gadolinium chloride inhibits the reaction [[Progesterone co-treated with Halothane] results in increased expression of ICAM1 mRNA]; Mifepristone inhibits the reaction [Halothane results in increased expression of ICAM1 mRNA]; Mifepristone inhibits the reaction [Progesterone promotes the reaction [Halothane results in increased expression of ICAM1 mRNA]]; Progesterone promotes the reaction [Halothane results in increased expression of ICAM1 mRNA]; U 0126 inhibits the reaction [[Progesterone co-treated with Halothane] results in increased expression of ICAM1 mRNA] |
CTD |
PMID:15564938 PMID:21501669 PMID:22157104 |
|
NCBI chr19:10,271,120...10,286,615
Ensembl chr19:10,271,093...10,286,615
|
|
G |
IFNG |
interferon gamma |
multiple interactions increases response to substance increases expression |
ISO |
PRF1 protein affects the reaction [Halothane results in increased expression of IFNG protein]; TLR4 protein affects the reaction [Halothane results in increased expression of IFNG protein] IFNG protein results in increased susceptibility to Halothane Halothane results in increased expression of IFNG mRNA |
CTD |
PMID:10422944 PMID:21245496 |
|
NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740
|
|
G |
IL17A |
interleukin 17A |
increases expression multiple interactions |
ISO |
Halothane results in increased expression of IL17A protein Estradiol inhibits the reaction [Halothane results in increased expression of IL17A protein]; fulvestrant inhibits the reaction [Estradiol inhibits the reaction [Halothane results in increased expression of IL17A protein]]; Mifepristone inhibits the reaction [Progesterone promotes the reaction [Halothane results in increased expression of IL17A protein]]; Progesterone promotes the reaction [Halothane results in increased expression of IL17A protein] |
CTD |
PMID:19633216 PMID:21501669 |
|
NCBI chr 6:52,186,375...52,190,638
Ensembl chr 6:52,186,375...52,190,638
|
|
G |
IL1B |
interleukin 1 beta |
multiple interactions increases expression |
ISO |
Halothane affects the reaction [IL1B protein affects the susceptibility to Phenylephrine]; Halothane affects the reaction [IL1B protein affects the susceptibility to Potassium Chloride]; Halothane inhibits the reaction [IL1B protein results in increased abundance of Cyclic GMP]; Halothane inhibits the reaction [IL1B protein results in increased expression of NOS2 mRNA]; Halothane inhibits the reaction [IL1B protein results in increased expression of NOS2 protein]; Halothane inhibits the reaction [IL1B protein results in increased expression of PTGS2 mRNA] Halothane results in increased expression of IL1B mRNA [Ryanodine co-treated with Halothane] results in increased expression of IL1B mRNA; Dantrolene inhibits the reaction [Halothane results in increased expression of IL1B mRNA]; Estradiol inhibits the reaction [Halothane results in increased expression of IL1B mRNA]; Fulvestrant inhibits the reaction [Estradiol inhibits the reaction [Halothane results in increased expression of IL1B mRNA]]; Mifepristone inhibits the reaction [Progesterone promotes the reaction [Halothane results in increased expression of IL1B mRNA]]; Progesterone promotes the reaction [Halothane results in increased expression of IL1B mRNA] |
CTD |
PMID:10422944 PMID:11506125 PMID:21501669 PMID:24747151 PMID:32795494 |
|
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
|
|
G |
IL6 |
interleukin 6 |
increases expression multiple interactions |
ISO |
Halothane results in increased expression of IL6 mRNA Estradiol inhibits the reaction [Halothane results in increased expression of IL6 mRNA]; fulvestrant inhibits the reaction [Estradiol inhibits the reaction [Halothane results in increased expression of IL6 mRNA]]; Mifepristone inhibits the reaction [Progesterone promotes the reaction [Halothane results in increased expression of IL6 mRNA]]; Progesterone promotes the reaction [Halothane results in increased expression of IL6 mRNA] |
CTD |
PMID:21501669 |
|
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
|
|
G |
ITGAM |
integrin subunit alpha M |
multiple interactions increases expression |
ISO |
Ryanodine promotes the reaction [Halothane results in increased expression of ITGAM mRNA] |
CTD |
PMID:32795494 |
|
NCBI chr16:31,259,975...31,332,877
Ensembl chr16:31,259,967...31,332,892
|
|
G |
ITPR1 |
inositol 1,4,5-trisphosphate receptor type 1 |
increases expression |
ISO |
Halothane results in increased expression of ITPR1 mRNA |
CTD |
PMID:32795494 |
|
NCBI chr 3:4,493,348...4,847,506
Ensembl chr 3:4,493,345...4,847,506
|
|
G |
ITPR3 |
inositol 1,4,5-trisphosphate receptor type 3 |
increases expression |
ISO |
Halothane results in increased expression of ITPR3 mRNA |
CTD |
PMID:32795494 |
|
NCBI chr 6:33,621,322...33,696,562
Ensembl chr 6:33,620,365...33,696,574
|
|
G |
KCNJ2 |
potassium inwardly rectifying channel subfamily J member 2 |
affects response to substance |
ISO |
KCNJ2 affects the susceptibility to Halothane |
CTD |
PMID:17546530 |
|
NCBI chr17:70,169,532...70,180,044
Ensembl chr17:70,168,673...70,180,044
|
|
G |
KCNK10 |
potassium two pore domain channel subfamily K member 10 |
multiple interactions |
EXP |
Halothane promotes the reaction [KCNK10 protein results in increased transport of Potassium] |
CTD |
PMID:16075240 |
|
NCBI chr14:88,180,108...88,326,912
Ensembl chr14:88,180,103...88,326,907
|
|
G |
KCNK2 |
potassium two pore domain channel subfamily K member 2 |
multiple interactions |
EXP |
Halothane promotes the reaction [KCNK2 protein results in increased transport of Potassium] |
CTD |
PMID:16075240 |
|
NCBI chr 1:215,005,542...215,237,090
Ensembl chr 1:215,005,775...215,237,090
|
|
G |
KCNK9 |
potassium two pore domain channel subfamily K member 9 |
multiple interactions |
EXP |
Halothane promotes the reaction [KCNK9 protein results in increased transport of Potassium] |
CTD |
PMID:11249964 |
|
NCBI chr 8:139,600,838...139,703,123
Ensembl chr 8:139,600,838...139,704,109
|
|
G |
MAPK1 |
mitogen-activated protein kinase 1 |
multiple interactions |
ISO |
[Progesterone co-treated with Halothane] results in increased phosphorylation of MAPK1 protein; U 0126 inhibits the reaction [[Progesterone co-treated with Halothane] results in increased phosphorylation of MAPK1 protein] |
CTD |
PMID:22157104 |
|
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
|
|
G |
MAPK14 |
mitogen-activated protein kinase 14 |
increases expression decreases expression |
ISO |
Halothane results in increased expression of MAPK14 mRNA Halothane results in decreased expression of MAPK14 protein |
CTD |
PMID:24598351 |
|
NCBI chr 6:36,027,808...36,124,214
Ensembl chr 6:36,027,752...36,122,511
|
|
G |
MAPK3 |
mitogen-activated protein kinase 3 |
multiple interactions |
ISO |
[Progesterone co-treated with Halothane] results in increased phosphorylation of MAPK3 protein; U 0126 inhibits the reaction [[Progesterone co-treated with Halothane] results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:22157104 |
|
NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
|
|
G |
MIR106B |
microRNA 106b |
decreases expression |
ISO |
Halothane results in decreased expression of MIR106B mRNA |
CTD |
PMID:24598351 |
|
NCBI chr 7:100,093,993...100,094,074
Ensembl chr 7:100,093,993...100,094,074
|
|
G |
MIR21 |
microRNA 21 |
affects expression |
ISO |
Halothane affects the expression of MIR21A mRNA |
CTD |
PMID:24598351 |
|
NCBI chr17:59,841,266...59,841,337
Ensembl chr17:59,841,266...59,841,337
|
|
G |
MPO |
myeloperoxidase |
decreases activity |
ISO |
Halothane results in decreased activity of MPO protein |
CTD |
PMID:15564938 |
|
NCBI chr17:58,269,855...58,280,935
Ensembl chr17:58,269,855...58,280,935
|
|
G |
NFKBIA |
NFKB inhibitor alpha |
increases phosphorylation multiple interactions |
ISO |
Halothane results in increased phosphorylation of NFKBIA protein Propofol inhibits the reaction [Halothane results in increased phosphorylation of NFKBIA protein] |
CTD |
PMID:16965849 |
|
NCBI chr14:35,401,513...35,404,749
Ensembl chr14:35,401,079...35,404,749
|
|
G |
NOS2 |
nitric oxide synthase 2 |
multiple interactions increases expression |
ISO |
Halothane inhibits the reaction [IL1B protein results in increased expression of NOS2 mRNA]; Halothane inhibits the reaction [IL1B protein results in increased expression of NOS2 protein]; Propofol inhibits the reaction [Halothane results in increased expression of NOS2 protein] |
CTD |
PMID:11506125 PMID:16965849 |
|
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
|
|
G |
POMC |
proopiomelanocortin |
increases secretion |
ISO |
Halothane results in increased secretion of POMC protein |
CTD |
PMID:2846107 |
|
NCBI chr 2:25,160,860...25,168,580
Ensembl chr 2:25,160,853...25,168,903
|
|
G |
PRF1 |
perforin 1 |
affects response to substance multiple interactions |
ISO |
PRF1 protein affects the susceptibility to Halothane PRF1 protein affects the reaction [Halothane results in increased expression of IFNG protein] |
CTD |
PMID:21245496 |
|
NCBI chr10:70,597,348...70,602,741
Ensembl chr10:70,597,348...70,602,759
|
|
G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
ISO |
Halothane inhibits the reaction [IL1B protein results in increased expression of PTGS2 mRNA] |
CTD |
PMID:11506125 |
|
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
|
|
G |
PTK2 |
protein tyrosine kinase 2 |
decreases phosphorylation |
EXP |
Halothane results in decreased phosphorylation of PTK2 protein |
CTD |
PMID:18215454 |
|
NCBI chr 8:140,657,900...141,002,079
Ensembl chr 8:140,657,900...141,002,216
|
|
G |
REN |
renin |
multiple interactions |
EXP |
[Halothane co-treated with Nitroprusside] results in increased activity of REN protein |
CTD |
PMID:3281763 |
|
NCBI chr 1:204,154,819...204,166,337
Ensembl chr 1:204,154,819...204,190,324
|
|
G |
RYR1 |
ryanodine receptor 1 |
increases activity increases expression increases response to substance multiple interactions |
EXP ISO |
Halothane results in increased activity of RYR1 protein Halothane results in increased expression of RYR1 mRNA RYR1 protein mutant form results in increased susceptibility to Halothane [Halothane results in increased activity of RYR1 protein] which affects the localization of Calcium |
CTD |
PMID:14641996 PMID:15210166 PMID:21485675 PMID:32795494 |
|
NCBI chr19:38,433,691...38,587,564
Ensembl chr19:38,433,691...38,595,273
|
|
G |
S100A8 |
S100 calcium binding protein A8 |
increases expression multiple interactions |
ISO EXP |
Halothane results in increased expression of S100A8 mRNA Dantrolene inhibits the reaction [Halothane results in increased expression of S100A8 mRNA]; Ryanodine promotes the reaction [Halothane results in increased expression of S100A8 mRNA] |
CTD |
PMID:24747151 PMID:28138970 PMID:32795494 |
|
NCBI chr 1:153,390,032...153,422,583
Ensembl chr 1:153,390,032...153,391,073
|
|
G |
S100A9 |
S100 calcium binding protein A9 |
increases expression multiple interactions |
ISO |
Halothane results in increased expression of S100A9 mRNA Dantrolene inhibits the reaction [Halothane results in increased expression of S100A9 mRNA]; Ryanodine promotes the reaction [Halothane results in increased expression of S100A9 mRNA] |
CTD |
PMID:24747151 PMID:32795494 |
|
NCBI chr 1:153,357,854...153,361,023
Ensembl chr 1:153,357,854...153,361,023
|
|
G |
SFTPC |
surfactant protein C |
decreases expression increases expression |
ISO |
Halothane results in decreased expression of SFTPC mRNA Halothane results in increased expression of SFTPC mRNA |
CTD |
PMID:10969314 |
|
NCBI chr 8:22,157,383...22,164,479
Ensembl chr 8:22,156,913...22,164,479
|
|
G |
STAT3 |
signal transducer and activator of transcription 3 |
multiple interactions increases expression |
ISO |
Halothane results in increased expression of and results in increased phosphorylation of STAT3 protein Halothane results in increased expression of STAT3 mRNA |
CTD |
PMID:24598351 |
|
NCBI chr17:42,313,324...42,388,442
Ensembl chr17:42,313,324...42,388,568
|
|
G |
TLR4 |
toll like receptor 4 |
multiple interactions |
ISO |
TLR4 protein affects the reaction [Halothane results in increased expression of IFNG protein] |
CTD |
PMID:21245496 |
|
NCBI chr 9:117,704,403...117,724,735
Ensembl chr 9:117,704,175...117,724,735
|
|
G |
TNF |
tumor necrosis factor |
increases expression multiple interactions decreases expression |
ISO |
Halothane results in increased expression of TNF mRNA Dantrolene inhibits the reaction [Halothane results in increased expression of TNF mRNA]; Estradiol inhibits the reaction [Halothane results in increased expression of TNF mRNA]; Fulvestrant inhibits the reaction [Estradiol inhibits the reaction [Halothane results in increased expression of TNF mRNA]]; Mifepristone inhibits the reaction [Halothane results in increased expression of TNF mRNA]; Mifepristone inhibits the reaction [Progesterone promotes the reaction [Halothane results in increased expression of TNF mRNA]]; Progesterone promotes the reaction [Halothane results in increased expression of TNF mRNA]; Ryanodine promotes the reaction [Halothane results in increased expression of TNF mRNA] Halothane results in decreased expression of TNF mRNA |
CTD |
PMID:10422944 PMID:15564938 PMID:21501669 PMID:22157104 PMID:24598351 PMID:32795494 More...
|
|
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
|
|
G |
VCAM1 |
vascular cell adhesion molecule 1 |
increases expression multiple interactions |
ISO |
Halothane results in increased expression of VCAM1 mRNA Dantrolene inhibits the reaction [Halothane results in increased expression of VCAM1 mRNA]; Ryanodine promotes the reaction [Halothane results in increased expression of VCAM1 mRNA] |
CTD |
PMID:32795494 |
|
NCBI chr 1:100,719,742...100,739,045
Ensembl chr 1:100,719,742...100,739,045
|
|